2023
Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications
AlAshqar A, Lulseged B, Mason-Otey A, Liang J, Begum U, Afrin S, Borahay M. Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications. Antioxidants 2023, 12: 807. PMID: 37107181, PMCID: PMC10135366, DOI: 10.3390/antiox12040807.Peer-Reviewed Original ResearchUterine fibroidsClinical implicationsOxidative stressFibroid developmentUterine fibroid developmentProfibrotic mechanismsBody of evidenceDietary factorsNeoplastic entitiesComplex pathobiologyCurrent evidenceFibroidsPathobiologyPharmaceutical antioxidantsAntioxidantsPathophysiologyTumorsDiagnosisHypoxiaBiomarkers
2019
Cardiometabolic Risk Factors and Benign Gynecologic Disorders.
AlAshqar A, Patzkowsky K, Afrin S, Wild R, Taylor HS, Borahay MA. Cardiometabolic Risk Factors and Benign Gynecologic Disorders. Obstetrical & Gynecological Survey 2019, 74: 661-673. PMID: 31755543, PMCID: PMC6986276, DOI: 10.1097/ogx.0000000000000718.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCardiometabolic risk factorsBenign gynecologic disordersRisk factorsUterine leiomyomaGynecologic disordersUterine leiomyoma pathogenesisBenign gynecologic conditionsPolycystic ovarian syndromeExtracellular matrix depositionCardiometabolic riskOvarian syndromeSystemic inflammationAtherosclerotic changesChronic inflammationGynecologic conditionsHyperestrogenic stateVitamin DInsulin resistanceDietary factorsCardiovascular diseasePreventive strategiesTherapeutic interventionsLeiomyoma pathogenesisClinical implicationsEndometriosis